1W Return
1M Return
6M Return
1Y Return
3Y Return
Start SIP in Samsrita Labs
Samsrita Labs Stock Performance
52 Week Low - High
Today’s Low - High
Open
Prev. Close
Total Traded Value
Samsrita Labs Fundamental
Market Cap (in crs)
Face Value
Turnover (in lacs)
Key Metrics
Qtr Change %
38.66% Fall from 52W High
-11.1
Dividend yield 1yr %
0
Samsrita Labs Key Financials
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
Samsrita Labs Quarterly Revenue
| Jun 2020 | Mar 2020 | Dec 2019 | Sep 2019 |
|---|---|---|---|
0.01 Cr | 0.24 Cr | 0.42 Cr | 0.35 Cr |
Samsrita Labs Yearly Revenue
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
0.31 Cr | 1.93 Cr | 0.16 Cr | 1.59 Cr | 2.12 Cr |
Samsrita Labs Quarterly Net Profit/Loss
| Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 |
|---|---|---|---|---|
-0.02 Cr | -0.04 Cr | -0.01 Cr | -0.19 Cr | -0.3 Cr |
Samsrita Labs Yearly Net Profit/Loss
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|
-0.25 Cr | -0.71 Cr | 1.5 Cr | -0.78 Cr | -1.98 Cr | -2.32 Cr |
Samsrita Labs Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
Current Price
5Day EMA
18.20
10Day EMA
17.00
12Day EMA
16.80
20Day EMA
16.40
26Day EMA
16.50
50Day EMA
17.50
100Day EMA
18.80
200Day EMA
19.30
5Day SMA
18.10
10Day SMA
16.30
20Day SMA
15.40
30Day SMA
16.10
50Day SMA
17.60
100Day SMA
20.10
150Day SMA
21.20
200Day SMA
20.10
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 627 Rs | 627 Rs |
Week Rs | 1714 Rs | 1869 Rs |
Month Rs | 1356 Rs | 1564 Rs |
Resistance & Support
19.85
Pivot
Resistance
First Resistance
19.85
Second Resistance
19.85
Third Resistance
19.85
Support
First Support
19.85
Second support
19.85
Third Support
19.85
Relative Strength Index
71
Money Flow Index
75.31
MACD
0.24
MACD Signal
-0.56
Average True Range
0.88
Average Directional Index
31.79
Rate of Change (21)
15.34
Rate of Change (125)
-20.63
Similar stocks
Similar Stocks
Peer comparison
Compare
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
29.40 | 12.19 | 32.36 | 18.91 | 21.41% | 41.79% | -8.61% | 18.44% | -26.35% | 0.00% | 0.00 | 89.16 | 2.43 | ||
GKB Ophthalmics Ltd. | 77.35 | - | - | - | - | - | - | - | - | - | - | - | - | |
Family Care Hospitals Ltd. | 4.62 | - | - | - | - | - | - | - | - | - | - | - | - | |
Transgene Biotek Ltd. | 3.82 | - | - | - | - | - | - | - | - | - | - | - | - | |
Medinova Diagnostic Services Ltd. | 41.50 | - | - | - | - | - | - | - | - | - | - | - | - | |
Sharma East India Hospitals & Medical Research Ltd. | 79.99 | - | - | - | - | - | - | - | - | - | - | - | - | |
Deccan Health Care Ltd. | 17.66 | - | - | - | - | - | - | - | - | - | - | - | - |
Samsrita Labs Company background
Founded in: 1996
Samsrita Labs Limited (Formerly known Dr Habeebullah Life Sciences Limited) was incorporated on January 25, 1996. The Company name was changed from Dr Habeebullah Life Sciences Limited to Samsrita Labs Limited on October 13, 2022. The Company, initially focused on three different verticals called, Stem cell related Hospitals, Molecular Diagnostics and RD in New Drug Discovery but due to other reasons, aimed to shifting into Biopharma activities like Trading, Exports Imports, manufacturing of Bulk drugs, APIs, Specialty drugs, RD etc through joint ventures or associations or mergers or by its own. The Company is engaged into the business of research experimental development on natural sciences and engineering, including bio pharma and hospital services also.In 2017, the Company changed its Main Objects clauses by venturing into the business of BioPharma and also entered the following areas like New Drug Discovery including New Molecular Entity (NME Pro Drug) Clinical Research Organization (CRO) related activities Stem Cell Lab, Research and Therapy Research and Development in Biotechnology Consultancy Division and Pharmacy Academic Services like Courses / Lectures / Seminars on Biotechnology, Pharma, Stem Cell Research and therapy, Clinical Research and animal studies etc. Nutraceuticals product development Trading, exporting and importing of medicinal drugs, chemicals, reagents etc.In 201617, the Company entered into a Collaborative Agreement with Krisani Bio Sciences Private Limited for further development of NASH (Fatty Liver) Molecule and Wilson Disease Molecule on revenue sharing basis and also entered into a Collaborative Agreement with Centre For liver Research And Diagnostics (CLRD) to use their land , building, equipment and other facilities to run their business of Hospital, Diagnostics, Pharmacy, Stem cell and other biotechnology laboratories on revenue sharing basis. A diversified healthcare company with innovation is at the forefront of research and development in stem cells regenerative medicine, new drug discovery, RNAi therapeutics, biomarker discovery. The Company was named after late Dr.CM Habeebullah, whose dedication and passion form the backbone of the Companys core values to provide affordable, world class cutting edge healthcare facilities to all. The Company has been established as an advanced center for research and excellence in areas of Stem Cell RD and Therapy, New Drug discovery, Molecular Diagnostics, Stem cell based multi Specialty Hospital and CRO.Krisani Bio Sciences Private Limited ceased to be the subsidiary of the Company with effect from 12.11.2021 and was made an Associate Company because of allotment of 64,00,000 equity shares at Rs. 10/ each by Krisani Bio Sciences Private Limited, erstwhile Subsidiary of the Company on a preferential basis and as a result the shareholding of the Company in Krisani Bio Sciences Private Limited came down from 51.33% to 32.91% in 2022.
Samsrita Labs FAQs
How to buy Samsrita Labs shares?
You can easily buy Samsrita Labs shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Please be aware that Samsrita Labs stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account
